Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Tech Weekly: Investors Still Cautious on Tech Stocks Post-Fed Meeting December 13, 2025 Editor’s Picks: Silver Price Sets New Record as Fed Cuts Rates, Gold Retakes US$4,300 December 13, 2025 Spartan Metals Terminates Investor Relations Agreement December 13, 2025
Editor’s Picks: Silver Price Sets New Record as Fed Cuts Rates, Gold Retakes US$4,300 December 13, 2025